Search results
Bristol Myers Gets CHMP Backing for Opdivo Combo in Bladder Cancer
Morningstar· 3 days agoSquibb on Friday said the European Medicines Agency's Committee for Medicinal Products for Human Use recommended expanded approval of its blockbuster cancer drug& ...
Exeliom to focus on gastric cancer landscape with immune modulating drug
Clinical Trials Arena via Yahoo Finance· 3 days agoThe company will be running three trials with EXL01, but the...in the treatment arm will receive...
Bristol-Myers stock falls despite Q1 beat (NYSE:BMY)
Seeking Alpha· 4 days agoBristol-Myers Squibb (BMY) stock dips even as the company topped consensus with Q1 2024 results, despite headwinds in its growth portfolio. Read more...
Bristol Myers posts quarterly loss, lays out $1.5 billion cost-saving plan
Reuters via Yahoo News· 4 days ago(Reuters) -Bristol Myers Squibb reported a first-quarter loss on Thursday as charges related to its...
Bristol Myers to cut 6% of workforce, trim drug pipeline
BioPharma Dive via Yahoo Finance· 4 days agoBristol Myers’ cuts come after a first quarter during which several of its prized new medicines...
Bristol-Myers' (BMY) to Report Q1 Earnings: What You Should Know
Zacks via Yahoo Finance· 6 days agoIncreased sales of the key immuno-oncology drug Opdivo on consistent label expansions for newer...
Bristol Myers posts quarterly loss, revenue rises 5%
Reuters· 4 days ago, opens new tab on Thursday reported a first-quarter loss as charges related to its recent acquisitions of Karuna Therapeutics, RayzeBio and Mirati...
Bristol-Myers (BMY) Q1 Loss Narrower Than Expected, Sales Beat
Zacks via Yahoo Finance· 3 days agoBristol-Myers' (BMY) first-quarter 2024 loss is narrower than estimated. Sales surpass the consensus...
Bristol-Myers Cuts '24 EPS View, Posts Narrower-Than-Seen 1Q Loss
Morningstar· 4 days agoBy Rob Curran Bristol-Myers Squibb cut its 2024 earnings projection even as the drug giant posted a narrower-than-anticipated first-quarter loss, reflecting the impact of ...
What's in Store for These 5 Pharma Bigwigs in Q1 Earnings?
Zacks via Yahoo Finance· 5 days agoBristol Myers’ revenues in the first quarter of 2024 are likely to have been boosted by the sales...